Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
2
×
clinical trials
life sciences
national blog main
national top stories
new york blog main
2
×
san diego blog main
san francisco blog main
antibiotics
arvinas
astellas pharma
astrazeneca
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
detroit
detroit blog main
detroit top stories
drugs
duchenne muscular dystrophy
dyne therapeutics
entasis therapeutics
facioscapulohumeral muscular dystrophy
fda
gene therapy
gritstone oncology
guardant health
indiana
indiana blog main
indiana top stories
ipo
What
biotechs
2
×
ipo
2
×
ipos
ago
chose
close
company
considering
data
device
diseases
drug
dyne
early
expected
experimental
eyes
firms
genetic
having
humans
life
long
make
medical
medicines
muscle
open
q
quarter
rare
reach
science
therapeutics
way
week
window
worked
Language
unset
Current search:
ipo
×
biotechs
×
" new york blog main "
×
" boston top stories "
×
boston
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way